While many medicines have played a role in treatment, there have been no FDA-approved treatments for moderate to severe hidradenitis suppurativa (HS). HUMIRA is the first and only FDA-approved hidradenitis suppurativa treatment.
While the exact cause is unknown, medical science has shown that HS is an immune disease. With HS, your body produces too much of a protein called TNF-alpha. This, along with other proteins, leads to increased inflammation. Which in turn leads to abscesses that may appear underneath or on the surface of your skin. So it’s active inside your body, but visible on the outside. HS is a chronic disease, which means it’s a disease that lasts a long time.
HUMIRA targets and blocks TNF-alpha, a specific source of inflammation that is thought to contribute to HS symptoms. Many HS patients who used HUMIRA in clinical trials experienced significant relief.
In just 3 months, HUMIRA was proven in many patients to reduce inflammatory nodules and abscesses by at least half without developing any new draining wounds and abscesses. Your results may vary.